...
search icon
legn-img

Legend Biotech Corp Share Price

LEGN
NSQ
$18.35
+$0.24
(1.33%)
1D
Industry: Biotechnology Sector: Health Care

Legend Biotech Corp Analyst Forecast

Legend Biotech Corp Share Price Chart

Legend Biotech Corp Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.34B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.79M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.09
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$16.24 L
$45.3 H
$18.35

About Legend Biotech Corp, Common Stock

Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma (NHL), acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, as well as a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. The company was founded in 2014 and is headquartered in Somerset, New Jersey. more

Industry: BiotechnologySector: Health Care

Legend Biotech Corp Stock Returns

Time FrameLEGNSectorS&P500
1-Week Return-1.02%0.72%-1.31%
1-Month Return-21.65%1.27%0.78%
3-Month Return-37.63%3.13%3.46%
6-Month Return-51%15.81%6.19%
1-Year Return-51.99%8.89%11.68%
3-Year Return-61.68%20.79%71.21%
5-Year Return-31.45%35.89%74.81%
10-Year Return-50.41%138.44%256.59%

Legend Biotech Corp Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue75.00M68.83M117.00M285.14M627.24M[{"date":"2020-12-31","value":11.96,"profit":true},{"date":"2021-12-31","value":10.97,"profit":true},{"date":"2022-12-31","value":18.65,"profit":true},{"date":"2023-12-31","value":45.46,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Cost of Revenue232.16M313.35M65.36M144.21M234.58M[{"date":"2020-12-31","value":74.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":20.86,"profit":true},{"date":"2023-12-31","value":46.02,"profit":true},{"date":"2024-12-31","value":74.86,"profit":true}]
Gross Profit75.00M68.83M51.64M140.93M392.66M[{"date":"2020-12-31","value":19.1,"profit":true},{"date":"2021-12-31","value":17.53,"profit":true},{"date":"2022-12-31","value":13.15,"profit":true},{"date":"2023-12-31","value":35.89,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Margin100.00%100.00%44.14%49.42%62.60%[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":44.14,"profit":true},{"date":"2023-12-31","value":49.42,"profit":true},{"date":"2024-12-31","value":62.6,"profit":true}]
Operating Expenses75.00M461.11M507.26M580.41M695.90M[{"date":"2020-12-31","value":10.78,"profit":true},{"date":"2021-12-31","value":66.26,"profit":true},{"date":"2022-12-31","value":72.89,"profit":true},{"date":"2023-12-31","value":83.4,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(313.35M)(392.29M)(455.62M)(439.49M)(303.24M)[{"date":"2020-12-31","value":-31334600000,"profit":false},{"date":"2021-12-31","value":-39228700000,"profit":false},{"date":"2022-12-31","value":-45562000000,"profit":false},{"date":"2023-12-31","value":-43948500000,"profit":false},{"date":"2024-12-31","value":-30324300000,"profit":false}]
Total Non-Operating Income/Expense(312.49M)(15.81M)(900.00K)(59.39M)184.70M[{"date":"2020-12-31","value":-169.19,"profit":false},{"date":"2021-12-31","value":-8.56,"profit":false},{"date":"2022-12-31","value":-0.49,"profit":false},{"date":"2023-12-31","value":-32.16,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(308.29M)(407.20M)(445.72M)(520.12M)(158.13M)[{"date":"2020-12-31","value":-30828500000,"profit":false},{"date":"2021-12-31","value":-40719600000,"profit":false},{"date":"2022-12-31","value":-44572400000,"profit":false},{"date":"2023-12-31","value":-52011800000,"profit":false},{"date":"2024-12-31","value":-15813300000,"profit":false}]
Income Taxes(41.91M)(3.61M)625.00K(1.86M)18.89M[{"date":"2020-12-31","value":-221.84,"profit":false},{"date":"2021-12-31","value":-19.13,"profit":false},{"date":"2022-12-31","value":3.31,"profit":true},{"date":"2023-12-31","value":-9.87,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(266.37M)(403.58M)(446.35M)(518.25M)(177.03M)[{"date":"2020-12-31","value":-26637300000,"profit":false},{"date":"2021-12-31","value":-40358200000,"profit":false},{"date":"2022-12-31","value":-44634900000,"profit":false},{"date":"2023-12-31","value":-51825400000,"profit":false},{"date":"2024-12-31","value":-17702600000,"profit":false}]
Income From Continuous Operations(303.48M)(386.21M)(446.35M)(509.31M)(177.03M)[{"date":"2020-12-31","value":-30347700000,"profit":false},{"date":"2021-12-31","value":-38620900000,"profit":false},{"date":"2022-12-31","value":-44634900000,"profit":false},{"date":"2023-12-31","value":-50931200000,"profit":false},{"date":"2024-12-31","value":-17702600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(266.37M)(403.58M)(446.35M)(518.25M)(177.03M)[{"date":"2020-12-31","value":-26637300000,"profit":false},{"date":"2021-12-31","value":-40358200000,"profit":false},{"date":"2022-12-31","value":-44634900000,"profit":false},{"date":"2023-12-31","value":-51825400000,"profit":false},{"date":"2024-12-31","value":-17702600000,"profit":false}]
EPS (Diluted)(2.49)(1.35)(1.58)(2.96)(0.80)[{"date":"2020-12-31","value":-249,"profit":false},{"date":"2021-12-31","value":-135,"profit":false},{"date":"2022-12-31","value":-158,"profit":false},{"date":"2023-12-31","value":-296,"profit":false},{"date":"2024-12-31","value":-80.38,"profit":false}]

Legend Biotech Corp Ratios

Legend Biotech Corp Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

LEGN
Cash Ratio 2.29
Current Ratio 2.86
Quick Ratio 2.80

Legend Biotech Corp Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LEGN
ROA (LTM) -6.92%
ROE (LTM) -22.53%

Legend Biotech Corp Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LEGN
Debt Ratio Lower is generally better. Negative is bad. 0.41
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.59

Legend Biotech Corp Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LEGN
Trailing PE NM
Forward PE 47.62
P/S (TTM) 3.57
P/B 3.21
Price/FCF 136
EV/R 2.93
EV/Ebitda NM

FAQs

What is Legend Biotech Corp share price today?

Legend Biotech Corp (LEGN) share price today is $18.35

Can Indians buy Legend Biotech Corp shares?

Yes, Indians can buy shares of Legend Biotech Corp (LEGN) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LEGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Legend Biotech Corp be purchased?

Yes, you can purchase fractional shares of Legend Biotech Corp (LEGN) via the Vested app. You can start investing in Legend Biotech Corp (LEGN) with a minimum investment of $1.

How to invest in Legend Biotech Corp shares from India?

You can invest in shares of Legend Biotech Corp (LEGN) via Vested in three simple steps:

  • Click on Sign Up or Invest in LEGN stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Legend Biotech Corp shares
What is Legend Biotech Corp 52-week high and low stock price?

The 52-week high price of Legend Biotech Corp (LEGN) is $45.3. The 52-week low price of Legend Biotech Corp (LEGN) is $16.24.

What is Legend Biotech Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Legend Biotech Corp (LEGN) is

What is Legend Biotech Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Legend Biotech Corp (LEGN) is 3.21

What is Legend Biotech Corp dividend yield?

The dividend yield of Legend Biotech Corp (LEGN) is 0.00%

What is the Market Cap of Legend Biotech Corp?

The market capitalization of Legend Biotech Corp (LEGN) is $3.34B

What is Legend Biotech Corp's stock symbol?

The stock symbol (or ticker) of Legend Biotech Corp is LEGN

How Can Investors Use Legend Biotech Corp Share Price Data for Long-Term Investment Decisions?

Consider the share price of Legend Biotech Corp as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Legend Biotech Corp has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Legend Biotech Corp shares for Indian investors?

When investing in Legend Biotech Corp shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Legend Biotech Corp stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Legend Biotech Corp share price with other stocks in the same sector?

Rather than merely checking the share price of Legend Biotech Corp and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Legend Biotech Corp stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top